Rethinking primary packaging: why mono-materials matter in pharma's sustainable future
Packaging sits at the intersection of regulation, sustainability, and manufacturing strategy. In pharmaceutical production, it’s often where change happens first, whether driven by new legislation, supply chain adaptation, or environmental goals. Materials once considered industry standard (multi-layer laminates, PVC-aluminum combinations) now face scrutiny as the pressure intensifies to adopt solutions that support recyclability without compromising performance.
What solutions are emerging in response? Chief among them is mono-material packaging: a single-substrate approach that simplifies recycling while aligning with circular economy principles.
The sustainability push in pharma packaging
Sustainability has evolved from corporate responsibility initiative to structural business priority in pharmaceutical manufacturing. Regulatory agencies worldwide are intensifying scrutiny of environmental performance across value chains, with primary packaging emerging as a critical focus area.
In Europe, this transformation is codified through the Packaging and Packaging Waste Regulation (EU) 2025/40, which mandates that all primary packaging for medicinal products achieve full recyclability by 2034. This regulation establishes comprehensive criteria for design-for-recycling, waste reduction, enhanced labeling, and substance restrictions.
Additional regulations are setting stricter expectations for recyclability performance and the use of recycled content. These evolving requirements influence how pharmaceutical companies approach packaging design, encouraging choices that support material recovery and minimize environmental impact.
Market dynamics reflect this regulatory momentum: the sustainable pharmaceutical packaging sector is projected to grow at a CAGR exceeding 15% between 2024 and 2032, signaling the industry's committed transition toward environmentally responsible practices.
Mono-material substrates are emerging as a viable pathway forward. By eliminating the material complexity inherent in traditional multi-layer laminates, they enable efficient recycling while maintaining the stringent pharmaceutical standards essential for product integrity.
What are mono-materials, and why are they essential?
Mono-material packaging comprises components manufactured entirely from a single material type, typically polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), high-density polyethylene (HDPE), or recyclable paper. This uniformity fundamentally distinguishes them from traditional multi-layer constructions, such as PVC-aluminum combinations, which are exceptionally difficult to separate and virtually impossible to recycle efficiently.
In pharmaceutical applications, mono-materials deliver clear operational advantages: they simplify post-consumer sorting, minimize contamination risk in recycling streams, and align with the recyclability thresholds defined by emerging regulatory frameworks. Unlike mixed-material solutions, mono-material substrates integrate seamlessly with existing mechanical recycling infrastructures, enhancing compatibility with circular economy objectives.
Beyond recyclability benefits, these materials support optimized packaging design. As detailed in this analysis of enabling mono-material packaging, advanced barrier coatings and functional inks now preserve essential product protection, against moisture, oxygen, and UV light, while maintaining recyclability. These solutions also deliver weight reduction, require fewer raw materials, and when combined with bio-based or recycled polymers, contribute significantly to carbon emission reduction.
Additionally, compostable materials represent a complementary sustainable approach for specific applications. Using compostable materials constitutes an advanced step toward sustainable packaging solutions, enabling complete biodegradation under appropriate conditions and further reducing environmental impact.
Industry momentum: pharma's investment in change
Progressive pharmaceutical companies are demonstrating mono-material viability across diverse applications, establishing partnerships with packaging suppliers to innovate in recyclable films and containers. The industry is systematically replacing traditional multi-material constructions with sustainable alternatives throughout primary packaging portfolios.
Many companies are currently transitioning blister pack production from PVC-aluminum combinations to recyclable mono-materials such as polypropylene. These efforts aim to improve recyclability while preserving the functional requirements of pharmaceutical products.
This shift is part of a broader strategy to simplify packaging structures, reduce overall plastic use, and introduce design elements that support end-of-life recovery. Approaches include the replacement of complex laminates with recyclable polymers and the use of digital printing technologies that facilitate sorting and minimize adhesive contamination.
Recent collaborations exemplify transformative potential. One case study reports that transitioning to a PET blister format led to a 38% reduction in carbon footprint, 78% lower water usage, and 53% less land consumption, while maintaining cost parity with traditional materials.
Enabling the transition: the role of print technology
Pharmaceutical packaging is evolving with new, recyclable and high-barrier films setting fresh demands for inline digital printing. Consistent adhesion, precise curing, and long-term durability are essential to meet both regulatory and operational expectations.
At Hapa, we deliver complete process control. By designing and manufacturing both our printing systems and inks, we ensure perfect alignment between hardware, software, and chemistry. This vertical integration guarantees performance stability and compliance across all substrate generations, from conventional laminates like alu, to next-generation mono-materials.
webjet machine for pharma packaging printing
The webjet H903 3D embodies this philosophy. Purpose-built for pharmaceutical lidding applications, it combines high-resolution digital printing with adaptive curing control and advanced substrate handling. Inline corona treatment options enable reliable adhesion even on low-tension films such as mono-PP or mono-PE. Integrated vision inspection, serialization, and data-management connectivity make the webjet a fully compliant, future-ready solution for automated production lines.
Our collaborative R&D approach extends this advantage. Together with customers and material partners, we validate substrates, refine ink formulations, and optimize curing parameters to ensure lasting print integrity and readability.
With Hapa, you gain more than a printing system you gain a proven process platform that adapts to new materials, safeguards compliance, and delivers exceptional print quality with minimal waste. This solution is ready for today’s production – and designed for tomorrow’s materials.
Looking ahead: a path forward
The pharmaceutical industry is entering an era where packaging decisions are inseparable from regulatory, environmental, and operational strategies. From substrate selection to serialized printing precision, sustainability considerations now influence every layer of the production chain.
Mono-materials represent a concrete advancement, but successful integration demands dedicated technologies, compliance-ready systems, and partnerships capable of supporting complex implementation within tightly regulated environments.
Hapa collaborates with pharmaceutical manufacturers to enable this transformation, from initial substrate testing through full inline deployment. Our in-house development of inks, print engines, and inspection systems delivers integrated print workflows specifically tailored for recyclable materials, serialization requirements, and evolving regulatory standards.
If your organization is navigating the transition to mono-material packaging, we stand ready to support your journey toward sustainable, compliant, and scalable operations. Connect with our team today.